AJ Lanigan: Sure. In Truth, pharma companies are producing big money with therapies like Keytruda and Opdivo that deal with PD-one and PD-L1. Here’s the super amazing section: visualize checkpoints as targeted traffic signals. You don’t want an immune procedure that’s running wild just like a freight train more than waiting for link from Social Bookmarking (4)